Advance Research Institute

What Advance Research Institute does

Advanced Research Institute (ARI) is a privately held, multi-specialty clinical research organization founded in 2000 in Ogden, Utah by Dr. John Lowe and Matt Lowe. ARI operates as a dedicated clinical trial site, conducting FDA-regulated studies across seven therapeutic areas: gastroenterology, endocrinology, neurology, cardiovascular, dermatology, otolaryngology, and urology. The firm serves three primary constituencies — pharmaceutical and biotech sponsors, Contract Research Organizations (CROs), and clinical trial participants — and runs in-house patient recruitment, screening, and regulatory functions. Its owned-and-operated footprint spans six locations across Utah (Ogden, Sandy, and a forthcoming Salt Lake City), Nevada (Reno), Colorado (Denver), Oregon (Portland), and Texas (Houston), staffed by 113 providers and 49 employees as of 2025.

ARI's core offering is end-to-end clinical trial execution, including early-phase planning, regulatory document management, patient enrollment, and post-marketing surveillance. Technology infrastructure centers on SiteVault, an eRegulatory system providing 24/7 document access to CROs and sponsors, supplemented by in-house recruitment technology, a free Fibroscan liver-health diagnostic clinic launched in 2024, and embedded partnerships with regional gastroenterology and primary care groups (Gastroenterology of the Rockies, Pacific Medical Group, Digestive Health Associates) that feed patient referrals into active protocols. The firm holds GCP, HIPAA, ISO, and FDA-compliant certifications and reports 1,000+ completed trials cumulatively.

Revenue is generated exclusively through professional services fees paid by sponsors and CROs for trial execution, enrollment, data collection, and regulatory compliance; participants receive care at no cost. Strategic CRO and sponsor relationships include Eli Lilly, IQVIA, PPD, ICON, Parexel, Syneos, Medpace, and Fortrea. The company is founder-controlled, bootstrapped (no venture or private equity capital disclosed), and professionally managed by a CEO installed in 2017, with a full C-suite covering regulatory, finance, operations, marketing, HR, and learning functions.

Name

Advance Research Institute

Legal name

Advanced Research Institute

Website

https://advresearch.org

Company type

Private

Founded year

2000

Operating status

Operating

Headcount range

11–50 employees

Short description

Advanced Research Institute is a privately held multi-specialty clinical research organization operating six sites across Utah, Nevada, Colorado, Oregon, and Texas. Founded in 2000, it conducts FDA-regulated trials for pharmaceutical sponsors and CROs across seven therapeutic areas.

Ownership category

akta.pro rank

Product category

Clinical Research Services

NAICS

Scientific Research and Development Services (5417)

SIC

Services-Health Services (8000)

akta.pro primary industry

Clinical Trial Site Operations & Study Coordination (HLAGACAE)

akta.pro secondary industries

Liver & GI Clinical Research (Trials Centers) (HLAKAEAL), Patient Recruitment, Site Feasibility & Trial Enablement CROs (HLAGAAAI)

Keywords

• Clinical trial services
• Multi-specialty research
• FDA-regulated trials
• Patient recruitment
• Gastroenterology research

Headquarters

HQ city

Ogden

HQ country

United States

HQ region

North America

Offices7 records

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Marketing or Sales, Technology or R&D

Revenue model

1. Clinical Trial Fees from Sponsors: ARI generates revenue by conducting clinical trials for pharmaceutical companies, biotech firms, and academic institutions. Sponsors pay for trial execution, patient enrollment, data collection, and regulatory compliance services.
2. CRO Partnership Revenue: Partnerships with Contract Research Organizations (CROs) including IQVIA, PPD, ICON, Parexel, Syneos, Medpace, and Fortrea for multi-site trial management and enrollment services.

Pricing tiers

Go-to-market motion2 records

Distribution channels4 records

Marketing channels5 records

Core offering

Advanced Research Institute operates as a multi-specialty clinical research organization conducting FDA-regulated clinical trials across therapeutic areas including gastroenterology, endocrinology, neurology, cardiovascular, dermatology, otolaryngology, and urology. The company provides end-to-end clinical trial services to pharmaceutical sponsors, biotech firms, and Contract Research Organizations (CROs), spanning early-phase planning, regulatory support, patient enrollment, data collection, and post-marketing surveillance. ARI operates five owned clinical research sites across Utah, Nevada, Colorado, and Oregon with 113 providers delivering trial execution services.

Product overview

Advanced Research Institute is a multi-specialty clinical research organization (CRO) offering comprehensive clinical trial services. The company operates across six locations in Utah, Nevada, Colorado, Oregon, and Texas, conducting FDA-regulated clinical trials in therapeutic areas including gastroenterology, endocrinology, neurology, cardiovascular, dermatology, otolaryngology, and urology. The core offering includes end-to-end solutions for sponsors and CROs with services spanning early-phase planning, regulatory support, rapid enrollment, and post-marketing surveillance. Supporting services include SiteVault eRegulatory systems for document management, in-house patient recruitment and screening, and a free Fibroscan clinic launched in 2024. The organization has completed over 400 clinical trials and provides care across multiple sites with board-certified physicians and expert clinical research coordinators.

Differentiator

Problem solved

Functional benefit

Products and services

• Clinical Trial Services
• CRO and Sponsor Services
• Free Fibroscan Clinic

Quantifiable outcome

• Trusted by over 20,000 participants across 7 states
• +2 more outcomes

Named customers8 records

Segments4 records

Ideal customer profiles3 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature2 records

Partnerships

Eleven partnerships are on record, tiered core.

• Eli LillycoreStrategic or Co-development PartnerMajor pharmaceutical sponsor partnering with ARI for clinical trial execution. ARI conducts trials for Eli Lilly's drug development programs.
• IQVIAcoreChannel Partner/ Reseller/ DistributorLeading CRO partner providing clinical trial management services. ARI serves as a research site for IQVIA-managed trials.
• PPDcoreChannel Partner/ Reseller/ DistributorCRO partner managing clinical trials. ARI collaborates with PPD for multi-site trial execution.
• ICONcoreChannel Partner/ Reseller/ DistributorCRO partner for clinical research. ARI partners with ICON for clinical trial management and enrollment.
• ParexelcoreChannel Partner/ Reseller/ DistributorCRO partner providing clinical research services. ARI collaborates with Parexel on clinical trials.
• SyneoscoreChannel Partner/ Reseller/ DistributorCRO partner for clinical trials. ARI works with Syneos on clinical research studies.
• MedpacecoreChannel Partner/ Reseller/ DistributorCRO partner providing clinical trial management. ARI partners with Medpace for clinical research.
• FortreacoreChannel Partner/ Reseller/ DistributorCRO partner for clinical trials. ARI collaborates with Fortrea on clinical research.
• Gastroenterology of the RockiescoreStrategic or Co-development PartnerDenver-based gastroenterology practice partnership providing comprehensive care to the Denver area. ARI provides clinical research services while the partner provides patient care.
• Pacific Medical GroupcoreStrategic or Co-development PartnerPortland-based medical group partnership providing comprehensive care to the Portland area. ARI provides clinical research services while the partner provides patient care.
• Digestive Health AssociatescoreStrategic or Co-development PartnerReno-based digestive health practice partnership. ARI partners with Digestive Health Associates to provide comprehensive care to the Reno/Salt Lake City community.

Scale indicators7 records

Recent moves11 records

Expansion highlights7 records

Direct peers

• ProTrials Research: Independent clinical research organization specializing in multi-therapeutic trials for sponsors. Comparable service offering to ARI's CRO and sponsor services.
• CenExel: Network of clinical research sites focused on CNS and other specialty indications. Directly comparable as a multi-site clinical research platform partnering with pharma sponsors and CROs.
• Flourish Research: Multi-site clinical research organization operating across the U.S. with similar therapeutic breadth and sponsor/CRO go-to-market as ARI.
• Velocity Clinical Research: Multi-specialty clinical research site network operating across the United States. Directly comparable to ARI in operating model (multi-site, multi-specialty, sponsor/CRO-facing) but at substantially larger scale and with institutional capital.
• DM Clinical Research: Multi-specialty clinical trial site network with locations across multiple U.S. states. Closely comparable operating model to ARI as a regional-to-national SMO expanding via de novo sites and partnerships.
• Elligo Health Research: PE-backed clinical research site network leveraging technology to expand trial access. Comparable to ARI as a multi-site SMO serving sponsors and CROs with diversified therapeutic areas.
• Accellacare: Clinical research site network (an IQVIA-owned platform) operating multi-specialty research sites. Comparable to ARI's SMO model though backed by a major CRO parent.

Broad incumbents

• Syneos Health: Global biopharmaceutical solutions organization offering both CRO and site-based services. A named ARI CRO partner and broader-scale incumbent in the same operational category.
• IQVIA: Largest global CRO and a core ARI partner. Overlaps with ARI through its Accellacare site network and broader clinical trial services portfolio, though much larger and diversified.
• ICON plc: Global CRO with significant site services capabilities following PRA Health Sciences acquisition. A direct ARI CRO partner and a broad incumbent competitor in clinical trial execution.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks5 records

Key highlights7 records

Customer concentration

• Xx.com/advresearchinst
• Facebookfacebook.com/ADVResearchInstitute
• LinkedInlinkedin.com/company/advanced-research-institute

Compliance4 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles12 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Advance Research Institute